3-(5-METHYL-THIOPHEN-2-YL)-PROPIONIC ACID, 95.0%, 100mg

Flacons à fond rond à trois cols cols latéraux parallèles, 4000 ml, 29/32, 14/23, 1 pièce

1-(Pyridin-2-ylcarbonyl)piperazine, 95.0%, 5g

Dasatinib, 95.0%, 10g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-cyclopentylpropanoic acid, 95.0%, 250mg

1-(2-(TERT-BUTOXY)ETHYL)-1H-IMIDAZOLE-4,5-DICARBOXYLIC ACID, 95.0%, 1g

tert-Butyl (2-(2-bromoethoxy)ethyl)carbamate, 95.0%, 5g

(R)-2-Amino-1,1,1-trifluoropropane hydrochloride, 99.0%, 5g

METHYL 4-(AMINOMETHYL)BICYCLO[2.2.2]OCTANE-1-CARBOXYLATE, 95.0%, 250mg

4-(1,3-Benzothiazol-2-yl)aniline, 97.0%, 100g

ETHYL 3-(2,6-DICHLOROPHENYL)-5-CYCLOPROPYLISOXAZOLE-4-CARBOXYLATE, 95.0%, 5g

QUINOXALINE-2,3-DICARBOXYLIC ACID, 95%, 100mg

7-Fluoro-6-methyl-benzo[b]thiophene-2-carboxylic acid methyl ester, 95.0%, 1g